The Fundamental Research in Oncology and Thrombosis (Frontline2) is a global survey, coordinated by the clinical research team at Thrombosis Research Institute (TRI), London. The survey is designed to evaluate how clinicians perceive the risk of venous thromboembolism in cancer patients and to provide insight into current strategies for thromboprophylaxis and management.

Visit the website at: